12 Mayıs 2021 Çarşamba

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12-to-15-year-olds.


By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/33B3aS4
zaman:
Etiketler:

Hiç yorum yok:

Yorum Gönder

Kaydol: Kayıt Yorumları (Atom)

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...